{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:24:45Z","timestamp":1715559885645},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,12]]},"DOI":"10.7759\/cureus.60128","type":"journal-article","created":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T10:19:19Z","timestamp":1715509159000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of COVID-19 Pandemic on Patients With Rheumatic Diseases in Medina, Saudi Arabia: An Observational Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Israa","family":"Safar Alsofyani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basim S","family":"Samman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salem  S","family":"Alhubayshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad T","family":"Ellahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseel B","family":"Alsaedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Almansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer V","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW, et al.. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020, 79:39-52. 10.1136\/annrheumdis-2019-215882","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.206","article-title":"Vaccination of patients with autoimmune inflammatory rheumatic diseases","volume":"11","author":"Westra J","year":"2015","unstructured":"Westra J, Rondaan C, van Assen S, Bijl M. Vaccination of patients with autoimmune inflammatory rheumatic diseases. Nat Rev Rheumatol. 2015, 11:135-45. 10.1038\/nrrheum.2014.206","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218296","article-title":"Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study","volume":"79","author":"Pablos JL","year":"2020","unstructured":"Pablos JL, Galindo M, Carmona L, et al.. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis. 2020, 79:1544-9. 10.1136\/annrheumdis-2020-218296","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0271","article-title":"The characteristics of 50 hospitalized COVID-19 patients with and without ARDS","volume":"117","author":"Dreher M","year":"2020","unstructured":"Dreher M, Kersten A, Bickenbach J, et al.. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Dtsch Arztebl Int. 2020, 117:271-8. 10.3238\/arztebl.2020.0271","journal-title":"Dtsch Arztebl Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00295-5","article-title":"Coronavirus: Update related to the current outbreak of COVID-19","volume":"9","author":"Gabutti G","year":"2020","unstructured":"Gabutti G, d'Anchera E, Sandri F, Savio M, Stefanati A. Coronavirus: Update related to the current outbreak of COVID-19. Infect Dis Ther. 2020, 9:241-53. 10.1007\/s40121-020-00295-5","journal-title":"Infect Dis Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05334-7","article-title":"COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series","volume":"39","author":"Ferri C","year":"2020","unstructured":"Ferri C, Giuggioli D, Raimondo V, et al.. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 2020, 39:3195-204. 10.1007\/s10067-020-05334-7","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04736-9","article-title":"Impact of COVID-19 pandemic on rheumatoid arthritis from a multi-centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient","volume":"41","author":"Abualfadl E","year":"2021","unstructured":"Abualfadl E, Ismail F, Shereef RR, et al.. Impact of COVID-19 pandemic on rheumatoid arthritis from a multi-centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient. Rheumatol Int. 2021, 41:345-53. 10.1007\/s00296-020-04736-9","journal-title":"Rheumatol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00562-2","article-title":"Rheumatic disease and COVID-19: epidemiology and outcomes","volume":"17","author":"Hyrich KL","year":"2021","unstructured":"Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021, 17:71-2. 10.1038\/s41584-020-00562-2","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04818-2","article-title":"Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience","volume":"41","author":"Migkos MP","year":"2021","unstructured":"Migkos MP, Kaltsonoudis E, Pelechas E, et al.. Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience. Rheumatol Int. 2021, 41:903-9. 10.1007\/s00296-021-04818-2","journal-title":"Rheumatol Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa694","article-title":"COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population","volume":"60","author":"Murray K","year":"2021","unstructured":"Murray K, Quinn S, Turk M, et al.. COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Rheumatology (Oxford). 2021, 60:902-6. 10.1093\/rheumatology\/keaa694","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13707","article-title":"Incidence and case fatality rate of COVID-19 in patients with inflammatory articular diseases","volume":"75","author":"Mena V\u00e1zquez N","year":"2021","unstructured":"Mena V\u00e1zquez N, Manrique-Arija S, Cabezudo-Garc\u00eda P, et al.. Incidence and case fatality rate of COVID-19 in patients with inflammatory articular diseases. Int J Clin Pract. 2021, 75:e13707. 10.1111\/ijcp.13707","journal-title":"Int J Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13959","article-title":"Impact of COVID-19 outbreak on rheumatic patients' perceptions and behaviors: a cross-sectional study","volume":"23","author":"Hassen LM","year":"2020","unstructured":"Hassen LM, Almaghlouth IA, Hassen IM, et al.. Impact of COVID-19 outbreak on rheumatic patients' perceptions and behaviors: a cross-sectional study. Int J Rheum Dis. 2020, 23:1541-9. 10.1111\/1756-185X.13959","journal-title":"Int J Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217984","article-title":"Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Freites Nu\u00f1ez DD","year":"2020","unstructured":"Freites Nu\u00f1ez DD, Leon L, Mucientes A, et al.. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020, 79:1393-9. 10.1136\/annrheumdis-2020-217984","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04676-4","article-title":"Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes","volume":"40","author":"Montero F","year":"2020","unstructured":"Montero F, Mart\u00ednez-Barrio J, Serrano-Benavente B, et al.. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatol Int. 2020, 40:1593-8. 10.1007\/s00296-020-04676-4","journal-title":"Rheumatol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/ rmdopen-2020-001464","article-title":"Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases","volume":"7","author":"Hasseli R","year":"2021","unstructured":"Hasseli R, Mueller-Ladner U, Hoyer BF, et al.. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. Rmd Open. 2021, 7:001464. 10.1136\/ rmdopen-2020-001464","journal-title":"Rmd Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102687","article-title":"COVID-19 infection among autoimmune rheumatic disease patients: data from an observational study and literature review","volume":"123","author":"Bakasis AD","year":"2021","unstructured":"Bakasis AD, Mavragani CP, Boki KA, et al.. COVID-19 infection among autoimmune rheumatic disease patients: data from an observational study and literature review. J Autoimmun. 2021, 123:102687. 10.1016\/j.jaut.2021.102687","journal-title":"J Autoimmun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00755-x","article-title":"COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations","volume":"18","author":"Grainger R","year":"2022","unstructured":"Grainger R, Kim AH, Conway R, Yazdany J, Robinson PC. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol. 2022, 18:191-204. 10.1038\/s41584-022-00755-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102778","article-title":"Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data","volume":"20","author":"Xu C","year":"2021","unstructured":"Xu C, Yi Z, Cai R, Chen R, Thong BY, Mu R. Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data. Autoimmun Rev. 2021, 20:102778. 10.1016\/j.autrev.2021.102778","journal-title":"Autoimmun Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/art.41619","article-title":"COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study","volume":"73","author":"D'Silva KM","year":"2021","unstructured":"D'Silva KM, Jorge A, Cohen A, McCormick N, Zhang Y, Wallace ZS, Choi HK. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study. Arthritis Rheumatol. 2021, 73:914-20. 10.1002\/art.41619","journal-title":"Arthritis Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102502","article-title":"SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients","volume":"112","author":"Zen M","year":"2020","unstructured":"Zen M, Fuzzi E, Astorri D, et al.. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J Autoimmun. 2020, 112:102502. 10.1016\/j.jaut.2020.102502","journal-title":"J Autoimmun"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.06.013","article-title":"Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: a review","volume":"75","author":"Grange L","year":"2020","unstructured":"Grange L, Guilpain P, Truchetet ME, Cracowski JL. Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: a review. Therapie. 2020, 75:335-42. 10.1016\/j.therap.2020.06.013","journal-title":"Therapie"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611318","article-title":"COVID-19 in association with development, course, and treatment of systemic autoimmune rheumatic diseases","volume":"11","author":"Lakota K","year":"2020","unstructured":"Lakota K, Perdan-Pirkmajer K, Ho\u010devar A, Sodin-Semrl S, Rotar \u017d, \u010cu\u010dnik S, \u017digon P. COVID-19 in association with development, course, and treatment of systemic autoimmune rheumatic diseases. Front Immunol. 2020, 11:611318. 10.3389\/fimmu.2020.611318","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00151-X","article-title":"Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study","volume":"3","author":"Shin YH","year":"2021","unstructured":"Shin YH, Shin JI, Moon SY, et al.. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study. Lancet Rheumatol. 2021, 3:e698-706. 10.1016\/S2665-9913(21)00151-X","journal-title":"Lancet Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au K","year":"2011","unstructured":"Au K, Reed G, Curtis JR, Kremer JM, Greenberg JD, Strand V, Furst DE. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011, 70:785-91. 10.1136\/ard.2010.128637","journal-title":"Ann Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219279","article-title":"Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic","volume":"80","author":"Serling-Boyd N","year":"2021","unstructured":"Serling-Boyd N, D'Silva KM, Hsu TY, et al.. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic. Ann Rheum Dis. 2021, 80:660-6. 10.1136\/annrheumdis-2020-219279","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1757","article-title":"Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study","volume":"174","author":"Deepak P","year":"2021","unstructured":"Deepak P, Kim W, Paley MA, et al.. Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study. Ann Intern Med. 2021, 174:1572-85. 10.7326\/M21-1757","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer V","year":"2021","unstructured":"Furer V, Eviatar T, Zisman D, et al.. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis. 2021, 80:1330-8. 10.1136\/annrheumdis-2021-220647","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313493032","article-title":"Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies","volume":"22","author":"Danza A","year":"2013","unstructured":"Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. 2013, 22:1286-94. 10.1177\/0961203313493032","journal-title":"Lupus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson P","year":"2020","unstructured":"Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020, 55:105932. 10.1016\/j.ijantimicag.2020.105932","journal-title":"Int J Antimicrob Agents"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.210288","article-title":"Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases","volume":"48","author":"Hazlewood GS","year":"2021","unstructured":"Hazlewood GS, Pardo JP, Barnabe C, et al.. Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases. J Rheumatol. 2021, 48:1330-9. 10.3899\/jrheum.210288","journal-title":"J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/241546-impact-of-covid-19-pandemic-on-patients-with-rheumatic-diseases-in-medina-saudi-arabia-an-observational-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T10:19:24Z","timestamp":1715509164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/241546-impact-of-covid-19-pandemic-on-patients-with-rheumatic-diseases-in-medina-saudi-arabia-an-observational-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,12]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.60128","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,12]]}}}